Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
Isatuximab, carfilzomib en dexamethason bij gerecidiveerd multipel myeloom (IKEMA)
aug 2021 | MM